Psychological distress and breast self-examination frequency in women at increased risk for hereditary or familial breast cancer

Community Genetics

Volumn 6, Issue 4, 2003, Pages 235-241

  Van Dooren, S ^a   Rijnsburger, A J ^a   Seynaeve, C ^a   Kriege, A ^a   Duivenvoorden, H J ^a   Bartels, C C M ^a   Essink Bot, M L ^a   De Koning, H J ^a   Tibben, A ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BRCA1 2; Breast cancer; Breast self examination; Hereditary risk; Psychological distress

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANCER RISK; CONTROLLED STUDY; DEMOGRAPHY; FAMILIAL CANCER; FEMALE; GENETIC RISK; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; MENTAL STRESS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RATING SCALE; STATISTICAL SIGNIFICANCE;

ADULT; ATTITUDE TO HEALTH; BREAST NEOPLASMS; BREAST SELF-EXAMINATION; DATA COLLECTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; STRESS, PSYCHOLOGICAL;

EID: 4444316408     PISSN: 14222795     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079385     Document Type: Article

References (32)

1. Miki Y, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
2. Wooster R, et al: Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-792.
3. Blackwood MA, Weber BL: BRCA1 and BRCA2: From molecular genetics to clinical medicine. J Clin Oncol 1998;16:1969-1977.
4. Ford D, et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62:676-689.
5. Thorlacius S, et al: Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 1998;352:1337-1339.
6. Meijers-Heijboer H, et al: Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002;31:55-59.
7. Vasen HF, et al: Current policies for surveillance and management in women at risk of breast and ovarian cancer: A survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group. Eur J Cancer 1998;34:1922-1926.
8. Brekelmans CT, et al: Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 2001;19:924-930.
9. Kriege M, et al: MRI screening for breast cancer in women with familial or genetic predisposition: Design of the Dutch National Study (MRISC). Fam Cancer 2001;1:163-168.
10. Hackshaw AK, Paul EA: Breast self-examination and death from breast cancer: A metaanalysis. Br J Cancer 2003;88:1047-1053.
11. Kash KM, et al: Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992;84:24-30.
12. Gagnon P, et al: Perception of breast cancer risk and psychological distress in women attending a surveillance program. Psychooncology 1996;5:259-269.
13. Epstein SA, et al: Excessive breast self-examination among first-degree relatives of newly diagnosed breast cancer patients. High-Risk Breast Cancer Consortium. Psychosomatics 1997;38:253-261.
14. Brain K, et al: Anxiety and adherence to breast self-examination in women with a family history of breast cancer. Psychosom Med 1999;61:181-187.
15. Erblich J, Bovbjerg DH, Valdimarsdottir HB: Psychological distress, health beliefs, and frequency of breast self-examination. J Behav Med 2000;23:277-292.
16. Lerman C, Kash K, Stefanek M: Younger women at increased risk for breast cancer: Perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Inst Monogr 1994;16:171-176.
17. Claus EB, Risch N, Thompson WD: Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 1994;73:643-651.
18. Brekelmans CT, et al: Family history of breast cancer and local recurrence after breast-conserving therapy. The Dutch Study Group on Local Recurrence after Breast Conservation (BORST). Eur J Cancer 1999;35:620-626.
19. Horowitz M, Wilner N, Alvarez W: Impact of Event Scale: A measure of subjective stress. Psychosom Med 1979;41:209-218.
20. Brom D, Kleber RJ: De Schokverwerkingslijst. Ned Tijdschr Psychol 1985;40:164-168.
21. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
22. Spinhoven P, et al: A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997;27:363-370.
23. Derogatis LR, Lipman RS, Covi L: SCL-90: An outpatient psychiatric rating scale - preliminary report. Psychopharmacol Bull 1973;9:13-28.
24. Arrindell W, Ettema J: Manual SCL-90. Lisse, The Netherlands, Swets and Zeitlinger, 1986.
25. Kaiser H: The varimax criterion for analytic rotation in factor analysis. Psychometrika 1958;23:187-200.
26. Kaiser H: An index of factorial simplicity. Psychometrika 1974;39:31-36.
27. Epstein SA, Lerman C: Excessive health behaviors in those at risk for physical disorder. J Psychosom Res 1997;43:223-225.
28. Baxter N; Canadian Task Force on Preventive Health Care: Preventive health care, 2001 update: Should women be routinely taught breast self-examination to screen for breast cancer? CMAJ 2001;164:1837-1846.
29. Thomas DB, et al: Randomized trial of breast self-examination in Shanghai: Final results. J Natl Cancer Inst 2002;94:1445-1457.
30. Eisinger F, et al: Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer. Lancet 1999;353:919-920.
31. Meijers-Heijboer EJ, et al: Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 2000;355:2015-2020.
32. Eisinger F, et al: Acceptability of prophylactic mastectomy in cancer-prone women. JAMA 2000;283:202-203.